[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100511200":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":34,"locations":40,"responsibleParty":55,"collaborators":25,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":25,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":25,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":25,"overallStatus":43,"whyStopped":25,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"IBSA Farmaceutici Italia Srl","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Lower dose (175mg)","EXPERIMENTAL","The study intervention consists of a single daily oral intake 175 mg of Salvia haenkei as soft capsule over a period of 3 months.",[13],"Dietary Supplement: Salvia haenkei 175mg",{"label":15,"type":10,"description":16,"interventionNames":17},"Higher dose (350mg)","The study intervention consists of a single daily oral intake 350 mg of Salvia haenkei as soft capsule over a period of 3 months.",[18],"Dietary Supplement: Salvia haenkei 350mg",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","Salvia haenkei 175mg","The product appears as a soft gel containing the dry extract of Salvia haenkei",[9],null,{"type":21,"name":27,"description":23,"armGroupLabels":28,"otherNames":25},"Salvia haenkei 350mg",[15],[30],{"name":31,"affiliation":32,"role":33},"Roberta Noseda, MD, PhD","Istituto di Scienze Farmacologiche della Svizzera Italiana, Lugano (Switzerland)","PRINCIPAL_INVESTIGATOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Tatiana Terrot","CONTACT","+41 91 811 7962","Tatiana.Terrot@eoc.ch",[41],{"facility":42,"status":43,"city":44,"state":25,"zip":25,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Ospedale Regionale di Lugano","RECRUITING","Lugano","Switzerland","CH",{"type":48,"coordinates":49},"Point",[50,51],8.96004,46.01008,{"lat":51,"lon":50},[54],{"name":36,"role":37,"phone":25,"phoneExt":25,"email":25},{"type":56,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100511200","evaluation-of-safety-and-tolerability-of-salvia-haenkei-extract-as-a-dietary-supplement-ingredient-100511200",false,"NCT05936346","Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient","Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient in a Healthy Population: a Randomized, Open Label, Parallel-arm, Two-dose Study","Inclusion Criteria:\n\n* Informed consent as documented by signature\n* Male or female\n* Age 55-65 years, inclusive\n* In good general health as evidenced by medical history and current health status\n* Willingness to maintain dietary and sports habits as of baseline\n* Willingness and ability to comply with the requirements of the study\n\nExclusion Criteria:\n\n* Body Mass Index \\\u003C 18.5 or ≥ 30\n* Difficulty in swallowing (dysphagia)\n* Known allergy or sensitivity to any ingredient of the study intervention\n* Any medical condition or clinically significant abnormalities in laboratory values (hematology, blood chemistry, urinalysis) at screening which in the judgment of the Investigator makes the subject unsuitable for the study\n* Planned or anticipated major surgical procedure during the subject's participation in this study\n* Inability or contraindications to undergo the study intervention\n* Inability to follow the procedures of the study (e.g. due to language problems, psychological disorders, dementia, etc.)\n* Use of any new vitamins, herbal or dietary supplements, functional foods and sports drink, of any kind, liable or presented as liable to enhance physical performances within one month prior to the start and during the study",true,"ALL","55 Years","65 Years",{"count":69,"type":70},50,"ESTIMATED","INTERVENTIONAL",[73],"NA","Evalution of the safety and tolerability of the oral administration of Salvia haenkei in a healthy population.",[76],"Aging","2025-01-21",{"date":79,"type":80},"2025-01-23","ACTUAL",{"date":82,"type":80},"2023-07-17",{"date":84,"type":70},"2025-04-30",{"name":5,"class":6},1]